C86.20
Enteropathy-type (intestinal) T-cell lymphoma not having achieved remission
Clinical Classification Guidelines
Inclusion Terms
- Enteropathy associated T-cell lymphoma NOS
- Enteropathy associated T-cell lymphoma not having achieved remission
- Enteropathy associated T-cell lymphoma with failed remission
- Enteropathy-type (intestinal) T-cell lymphoma NOS
- Enteropathy-type (intestinal) T-cell lymphoma with failed remission
Medical Intelligence & Overview
Enteropathy-type (intestinal) T-cell lymphoma is a rare form of non-Hodgkin lymphoma that occurs in the intestines. It develops from T-lymphocytes, a type of white blood cell involved in immune responses. When this lymphoma has not responded to initial treatments or has relapsed, it is classified as 'not having achieved remission,' indicating ongoing disease activity. This guide aims to provide clear information about this condition, its causes, symptoms, diagnosis, and treatment options.
Causes & Symptoms
Clinical Causes: Chronic immune system activation, often associated with celiac disease or other autoimmune conditions Prolonged exposure to gluten in susceptible individuals, especially those with celiac disease Genetic factors influencing immune function Environmental factors that may trigger immune dysfunction Potential links to other immune disorders affecting the gastrointestinal tract
Key Symptoms: Persistent diarrhea that may be severe and unresponsive to standard treatments Abdominal pain or cramping Unintentional weight loss Fatigue and weakness Fever and night sweats Feeling of fullness or bloating in the abdomen Gastrointestinal bleeding leading to anemia and fatigue Changes in bowel habits, such as increased frequency or abnormal stool appearance
Diagnostic & Treatment
Diagnosis Path: Medical history assessment, including previous diagnosis of celiac disease or autoimmune conditions Endoscopic procedures to visualize the gastrointestinal tract and obtain tissue biopsies Histopathological examination of biopsy samples to identify abnormal lymphoid cells Immunophenotyping tests to determine the specific type of lymphoma Imaging studies like CT scans or PET scans to assess the extent of disease Blood tests to evaluate overall health and identify anemia or other related conditions
Treatment Protocols: Chemotherapy regimens tailored to aggressive lymphomas, often including combination drug therapy Targeted therapies that focus on specific molecular features of the lymphoma Stem cell or bone marrow transplant in select cases to restore healthy blood cell production Supportive care to manage symptoms and improve quality of life, including nutritional support and treatment of infections Clinical trials exploring new treatment approaches for refractory or relapsed disease
Clinical Advice & FAQs
Billing Guidance
Is C86.20 a billable ICD-10 code?
Yes, C86.20 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C86.20?
Clinical documentation must specify the nature of Enteropathy-type (intestinal) T-cell lymphoma not having achieved remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference